|
|
|
Insider
Information: |
Christensen Jamie |
Relationship: |
Director |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
40,600 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$0 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
40,600 |
|
|
Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
14
|
Stock
price went up :
|
0
|
3
|
Stock
price went down : |
0
|
11
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-183.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Mirati Therapeutics, Inc. |
MRTX |
|
2024-01-23 |
0 |
2014-12-05 |
0 |
Premium* |
|
Tango Therapeutics Ord Shs |
TNGX |
Director |
2020-09-02 |
40,600 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
61 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
MRTX |
Mirati Therapeutics, Inc. |
SVP, Chief Scientific Officer |
|
2018-03-09 |
4 |
AS |
$33.00 |
$726,040 |
D/D |
(22,000) |
2,877 |
0 |
- |
|
MRTX |
Mirati Therapeutics, Inc. |
SVP, Chief Scientific Officer |
|
2018-06-26 |
4 |
OE |
$5.40 |
$28,123 |
D/D |
5,208 |
8,085 |
0 |
- |
|
MRTX |
Mirati Therapeutics, Inc. |
SVP, Chief Scientific Officer |
|
2018-06-26 |
4 |
AS |
$48.62 |
$253,965 |
D/D |
(5,208) |
3,394 |
0 |
- |
|
MRTX |
Mirati Therapeutics, Inc. |
SVP, Chief Scientific Officer |
|
2018-06-27 |
4 |
OE |
$5.50 |
$27,495 |
D/D |
4,999 |
8,393 |
0 |
- |
|
MRTX |
Mirati Therapeutics, Inc. |
SVP, Chief Scientific Officer |
|
2018-06-27 |
4 |
AS |
$49.43 |
$247,665 |
D/D |
(4,999) |
3,394 |
0 |
- |
|
MRTX |
Mirati Therapeutics, Inc. |
EVP, Chief Scientific Officer |
|
2018-12-26 |
4 |
OE |
$17.41 |
$89,992 |
D/D |
5,169 |
8,789 |
0 |
- |
|
MRTX |
Mirati Therapeutics, Inc. |
EVP, Chief Scientific Officer |
|
2019-12-23 |
4 |
OE |
$5.40 |
$36,246 |
D/D |
6,666 |
13,326 |
0 |
- |
|
MRTX |
Mirati Therapeutics, Inc. |
EVP, Chief Scientific Officer |
|
2019-12-23 |
4 |
AS |
$125.00 |
$833,250 |
D/D |
(6,666) |
9,159 |
0 |
- |
|
MRTX |
Mirati Therapeutics, Inc. |
EVP, Chief Scientific Officer |
|
2020-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
15,625 |
24,784 |
0 |
- |
|
MRTX |
Mirati Therapeutics, Inc. |
EVP, Chief Scientific Officer |
|
2020-03-26 |
4 |
OE |
$5.40 |
$124,983 |
D/D |
8,058 |
32,842 |
0 |
- |
|
MRTX |
Mirati Therapeutics, Inc. |
EVP, Chief Scientific Officer |
|
2020-05-21 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
37,842 |
0 |
- |
|
TNGX |
Tango Therapeutics Ord Sh... |
Director |
|
2020-09-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
40,600 |
|
- |
|
MRTX |
Mirati Therapeutics, Inc. |
EVP, Chief Scientific Officer |
|
2020-11-02 |
4 |
OE |
$5.40 |
$90,493 |
D/D |
10,879 |
48,721 |
0 |
- |
|
MRTX |
Mirati Therapeutics, Inc. |
EVP, Chief Scientific Officer |
|
2021-01-06 |
4 |
S |
$210.28 |
$306,961 |
D/D |
(1,459) |
47,262 |
0 |
% |
|
MRTX |
Mirati Therapeutics, Inc. |
EVP, Chief Scientific Officer |
|
2021-01-15 |
4 |
A |
$0.00 |
$0 |
D/D |
7,023 |
54,285 |
0 |
- |
|
MRTX |
Mirati Therapeutics, Inc. |
EVP, Chief Scientific Officer |
|
2021-05-24 |
4 |
S |
$154.34 |
$67,138 |
D/D |
(435) |
53,850 |
0 |
% |
|
MRTX |
Mirati Therapeutics, Inc. |
EVP, Chief Scientific Officer |
|
2021-12-03 |
4 |
A |
$0.00 |
$0 |
D/D |
6,856 |
60,706 |
0 |
- |
|
MRTX |
Mirati Therapeutics, Inc. |
EVP, Chief Scientific Officer |
|
2021-12-06 |
4 |
S |
$130.78 |
$157,078 |
D/D |
(1,201) |
59,505 |
0 |
% |
|
MRTX |
Mirati Therapeutics, Inc. |
EVP, Chief Scientific Officer |
|
2021-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
19,149 |
78,742 |
0 |
- |
|
MRTX |
Mirati Therapeutics, Inc. |
EVP, Chief Scientific Officer |
|
2022-01-04 |
4 |
S |
$147.72 |
$213,017 |
D/D |
(1,442) |
77,300 |
0 |
% |
|
MRTX |
Mirati Therapeutics, Inc. |
EVP, Chief Scientific Officer |
|
2022-01-14 |
4 |
A |
$0.00 |
$0 |
D/D |
10,755 |
88,055 |
0 |
- |
|
MRTX |
Mirati Therapeutics, Inc. |
EVP, Chief Scientific Officer |
|
2022-01-18 |
4 |
S |
$120.51 |
$75,558 |
D/D |
(627) |
87,428 |
0 |
% |
|
MRTX |
Mirati Therapeutics, Inc. |
EVP, Chief Scientific Officer |
|
2022-09-07 |
4 |
A |
$0.00 |
$0 |
D/D |
19,149 |
106,089 |
0 |
- |
|
MRTX |
Mirati Therapeutics, Inc. |
EVP, Chief Scientific Officer |
|
2022-12-02 |
4 |
S |
$90.19 |
$155,667 |
D/D |
(1,726) |
104,482 |
0 |
% |
|
MRTX |
Mirati Therapeutics, Inc. |
EVP, Chief Scientific Officer |
|
2022-12-16 |
4 |
S |
$43.00 |
$103,624 |
D/D |
(2,410) |
102,072 |
0 |
% |
|
61 Records found
|
|
Page 2 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|